StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3059% below fair value
$3.06−0.06 (-1.92%)

Close on Nov 19, 2026Market cap $762.51MP/E –Yield –

Ardelyx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Ardelyx's free cash flow for the twelve months ending Jun 30, 2026 was -$17.92M. For fiscal 2025 it was -$43.98M. The highest annual figure on record is $21.85M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$43.98M–
FY2024Dec 31, 2024-$45.82M–
FY2023Dec 31, 2023-$90.06M–
FY2022Dec 31, 2022-$70.10M–
FY2021Dec 31, 2021-$154.42M–
FY2020Dec 31, 2020-$81.76M–
FY2019Dec 31, 2019-$76.81M–
FY2018Dec 31, 2018-$70.59M–
FY2017Dec 31, 2017-$67.55M–
FY2016Dec 31, 2016-$97.40M–
FY2015Dec 31, 2015-$75.29M-752.4%
FY2014Dec 31, 2014$11.54M+652.8%
FY2013Dec 31, 2013$1.53M-93.0%
FY2012Dec 31, 2012$21.85M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.41M–
Q1 FY2026Mar 31, 2026-$32.31M–
Q4 FY2025Dec 31, 2025$20.59M+123.4%
Q3 FY2025Sep 30, 2025$209.00K-42.6%
Q2 FY2025Jun 30, 2025-$25.99M–
Q1 FY2025Mar 31, 2025-$38.78M–
Q4 FY2024Dec 31, 2024$9.22M–
Q3 FY2024Sep 30, 2024$364.00K–
Q2 FY2024Jun 30, 2024-$19.53M–
Q1 FY2024Mar 31, 2024-$35.87M–
Q4 FY2023Dec 31, 2023-$8.76M-161.6%
Q3 FY2023Sep 30, 2023-$21.66M–
Q2 FY2023Jun 30, 2023-$14.83M–
Q1 FY2023Mar 31, 2023-$44.81M–
Q4 FY2022Dec 31, 2022$14.23M–
Q3 FY2022Sep 30, 2022-$25.43M–
Q2 FY2022Jun 30, 2022-$31.28M–
Q1 FY2022Mar 31, 2022-$27.62M–
Q4 FY2021Dec 31, 2021-$39.37M–
Q3 FY2021Sep 30, 2021-$35.03M–
Q2 FY2021Jun 30, 2021-$35.02M–
Q1 FY2021Mar 31, 2021-$45.00M–
Q4 FY2020Dec 31, 2020-$17.84M–
Q3 FY2020Sep 30, 2020-$19.93M–
Q2 FY2020Jun 30, 2020-$19.02M–
Q1 FY2020Mar 31, 2020-$24.97M–
Q4 FY2019Dec 31, 2019-$11.14M–
Q3 FY2019Sep 30, 2019-$20.73M–
Q2 FY2019Jun 30, 2019-$27.87M–
Q1 FY2019Mar 31, 2019-$17.08M–
Q4 FY2018Dec 31, 2018-$18.72M-500.9%
Q3 FY2018Sep 30, 2018-$26.99M–
Q2 FY2018Jun 30, 2018-$18.02M–
Q1 FY2018Mar 31, 2018-$6.86M–
Q4 FY2017Dec 31, 2017$4.67M–
Q3 FY2017Sep 30, 2017-$19.66M–
Q2 FY2017Jun 30, 2017-$24.68M–
Q1 FY2017Mar 31, 2017-$27.88M–
Q4 FY2016Dec 31, 2016-$29.51M–
Q3 FY2016Sep 30, 2016-$26.25M–

More Ardelyx figures

See a number that looks wrong?